Colorectal Carcinoma — Trials

Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,010 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 344
Recruiting: 194
Ph III recruiting: 12
Growth YoY: +2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

clinicaltrialsPublishedShowing 51–100 of 1,010 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02997228	Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study	active not recruiting	Phase 3	120	National Cancer Institute (NCI)NIH	1	Sep 8, 2026	clinicaltrials
NCT03715933	Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas	recruiting	Phase 1	411	Inhibrx Biosciences, IncINDUSTRY	6	Sep 8, 2026	clinicaltrials